We drive the development and delivery of next-generation therapies, leverage data to identify optimal and more personalized treatment approaches, and empower myeloma patients and the broader community with information and resources to extend their lives. Central to our mission is our commitment to advancing health equity so that all myeloma patients can benefit from the scientific and clinical advances we pursue. Since our inception, the MMRF has committed over $500 million for research, opened nearly 100 clinical trials, and helped bring 15+ FDA-approved therapies to market, which have tripled the life expectancy of myeloma patients.
To accelerate a cure for each and every multiple myeloma patient.
A world free of multiple myeloma.
At the MMRF, our core values define both who we are and how we work together with the myeloma community. We believe in building a culture that will help us pursue our highest-level mission, which has not changed since our inception in 1998. Our five core values are expressed below:
Racial and ethnic biases, social and financial disparities, and lesser access to quality care are all contributing factors to the outcomes facing underserved populations. We believe research opportunities should be more equitable and remove barriers to treatment. Our goals focus on greater inclusivity in research to improve patient health outcomes.